Emparedados Boricua de Bayamón PR, está alertando que el producto “Emparedados Boricua – Pollo y Queso” empacados en unidades de 6.5 oz. contienen huevos que no están declarados en la etiqueta. Personas que son alérgicas al huevo están en riesgo de serias reacciones alérgicas si consumen estos productos.
Emparedados Boricua Issues Allergen Alert For Its Products "Emparedados Boricua – Chicken and Cheese"
Emparedados Boricua located in Bayamón PR, is warning that the product “Emparedados Boricua – Chicken and Cheese” packaged in units of 6.5 oz. contains eggs that are not declared on the label. People who are allergic to eggs are at risk of serious allergic reactions if they consume these products.
FDA approves first sublingual allergen extract for the treatment of certain grass pollen allergies
The U.S. Food and Drug Administration recently approved Oralair to treat allergic rhinitis (hay fever) with or without conjunctivitis (eye inflammation) that is induced by certain grass pollens in people ages 10 through 65 years. Oralair is the first sublingual (under the tongue) allergen extract approved in the United States. After administration of the first dose at the health care provider’s office, where the patient can be observed for potential adverse reactions, Oralair can be taken at home.
Dräger Issues Voluntary Nationwide Recall of Optional PS500 Power Supply for Evita V500 and Babylog VN500 Ventilators
Today Dräger initiated a nationwide recall of the optional PS500 Power Supply Unit used with the Evita V500 and Babylog VN500 ventilators. This voluntary action was a result of an internal investigation by Dräger into complaints that found that the batteries installed in the PS500 depleted much earlier than expected, although the battery indicator showed a significantly charged battery.
Lao Thai Nam Corp. Voluntarily Recalls Number One Sompa Salted Fish, Because of Possible Health Risk
Lao Thai Nam Corp., of Dallas, Texas is recalling Number One Sompa Salted Fish, because it has the potential to be contaminated with Clostridium botulinum, a bacterium which can cause life-threatening illness or death. Consumers are warned not to use the product even if it does not look or smell spoiled.
Vita Food Products Issues Voluntary Recall of ELF Herring Fillets in Wine Sauce Containing Undeclared Milk
Vita Food Products, Inc. of Chicago, Illinois is notifying the public that it is recalling 2,280 individual plastic jars of 12 ounce Elf Herring Fillets in Wine Sauce that actually contains herring fillets in sour cream and therefore contains undeclared milk.
Fresh Express Issues Recall of Limited Quantity of Already Expired Italian Salad Due to Possible Health Risk, No Illnesses Cited
Fresh Express Incorporated has issued a recall of a limited number of cases of 10 oz. and 6oz. Italian Salad with the already expired Use-by Date of March 26 and a Product Code of H071A11A due to a possible health risk from Listeria monocytogenes.
Nova Products, Inc. Issues Voluntary Nationwide Recall of Dietary Supplements with Undeclared Active Pharmaceutical Ingredients
Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling the following products: African Black Ant (Lot# 2006-000926), Black Ant (Lot# 2006-3627878), XZen Gold (Lot# 130310GL), ZXen Platinum (Lot# 130520PL), XZen 1200 (Lot# 13051012), XZone Gold (Lot# 131110GL), and XZone 1200 (Lot# 13071012) at the retail level. Lot numbers are identified on the back or side of each product. FDA laboratory analysis on these products has determined that they contain undeclared amounts of sildenafil and tadalafil, active ingredients of FDA-approved drugs used to treat erectile dysfunction.
FDA approves first long-acting recombinant coagulation Factor IX concentrate for patients with Hemophilia B
The U.S. Food and Drug Administration today approved Alprolix, Coagulation Factor IX (Recombinant), Fc Fusion Protein, for use in adults and children who have Hemophilia B. Alprolix is the first Hemophilia B treatment designed to require less frequent injections when used to prevent or reduce the frequency of bleeding.
FDA approves Topamax for migraine prevention in adolescents
Today, the U.S. Food and Drug Administration approved Topamax (topiramate) for prevention (prophylaxis) of migraine headaches in adolescents ages 12 to 17. This is the first FDA approval of a drug for migraine prevention in this age group. The medication is taken on a daily basis to reduce the frequency of migraine headaches.